PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain

PHASE4CompletedINTERVENTIONAL

Enrollment

359

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

April 30, 2014

Conditions

Cancer

Interventions

DRUG

Oxycodone/Naloxone

Twice daily

Trial Locations (1)

13 sites including Yeungnam University Medical Center, Daegu

All Listed Sponsors

lead

Mundipharma Korea Ltd

INDUSTRY

NCT01719757 - PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain | Biotech Hunter | Biotech Hunter